Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
107 hedge funds and large institutions have $504M invested in Five Prime Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 11 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
43% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 28
19% more capital invested
Capital invested by funds: $425M → $504M (+$78.9M)
15% more funds holding
Funds holding: 93 → 107 (+14)
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $412K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$15.1M |
| 2 |
RI
RTW Investments
New York
|
+$12.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.8M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$7.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.03M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$5.84M |
| 5 |
AIC
AWM Investment Company
New York
|
-$4.05M |
FPRX Hedge Fund Activity: Q2 2015 in Review
107 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2015, worth a combined $504M — up 19% from $425M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FPRX positions and 11 closed out — a net gain of 14 holders — while 40 added to existing stakes and 28 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $15.1M. The largest seller was Millennium Management, cutting an estimated $12.8M.
- 107 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2015, up from 93 in Q1 2015.
- Funds reported $504M of Five Prime Therapeutics, Inc. stock for Q2 2015, up 19% quarter-over-quarter.
- 25 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2015 and 11 closed out, a net change of +14 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q2 2015 was Great Point Partners, an estimated $15.1M added.
- The largest Five Prime Therapeutics, Inc. seller in Q2 2015 was Millennium Management, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2015.